PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Jul-2022 STEMart Introduces New Antibiotic Potency Tests for Medical Devices STEMart
04-Jul-2022 CD Bioparticles Expands Lipid System Portfolio by the Launch of Sphingolipids CD Bioparticles
04-Jul-2022 Creative Diagnostics Introduces New Cell-based ELISA Services Creative Diagnostics
04-Jul-2022 CD Bioparticles Announces the Launch of Colored Polystyrene Particles CD Bioparticles
04-Jul-2022 Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research Creative Diagnostics
04-Jul-2022 Poultry Diagnostics Market Worth USD 1.1 Billion By 2028 At 10.5% CAGR From 2022 To 2028 – Report by Future Market Insights MARKITWIRED
04-Jul-2022 Physiotherapy Equipment Market In-Depth Analysis, Growth Strategies and Comprehensive Forecast to 2030 MARKITWIRED
04-Jul-2022 Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission Relief Therapeutics Holding SA
04-Jul-2022 Airway Management Devices Market Is Set to Expand at A CAGR Of 3.2% To Reach US$ 1.81 Billion During the Forecast Period 2022-2028 MARKITWIRED
04-Jul-2022 FUSE-AI supports German pharmacies in digitization Xlife Sciences AG
04-Jul-2022 Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk Relief Therapeutics Holding SA
04-Jul-2022 SKAN Group AG closes announced increase of its stake in Aseptic Technologies SKAN AG
04-Jul-2022 Vital Signs Monitoring Devices Market Is Set to Experience a Significant Growth Of 8.4% CAGR From 2022 To 2030 MARKITWIRED
04-Jul-2022 Lab Automation Market Is Set to Expand at A CAGR Of 9.6% To Reach US$ 3 Billion During the Forecast To 2027 MARKITWIRED
03-Jul-2022 ORPEA Announces Major Changes in Its Board of Directors Businesswire
02-Jul-2022 Seagen Announces Results from Pivotal MOUNTAINEER Trial Demonstrating Clinically Meaningful Antitumor Activity of TUKYSA® (tucatinib) in Combination with Trastuzumab in Previously Treated HER2-Positive Metastatic Colorectal Cancer Businesswire
01-Jul-2022 Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Businesswire
01-Jul-2022 MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Businesswire
01-Jul-2022 2022 Good Documentation Practices Webinar - Look at Documentation Practices That Should be Avoided - ResearchAndMarkets.com Businesswire
01-Jul-2022 Regulatory Affairs Outsourcing Market Report 2022: Increasing Use of Digital Platforms/Solutions in Regulatory Affairs Driving Growth - ResearchAndMarkets.com Businesswire